| Variables | Clinical outcome | Total n = 229 | P value | |
| Recovered n = 193 | Death n = 36 | |||
| Leukocytosis | 135 (69.9%) | 31 (86.1%) | 166 (72.5%) | 0.046 |
| Low RBCs | 36 (18.7%) | 12 (33.35) | 48 (21%) | 0.047 |
| Low Hemoglobin | 75 (38.9%) | 21 (58.3%) | 96 (41.9%) | 0.030 |
| Thrombocytopenia | 9 (4.7%) | 3 (8.3%) | 12 (5.2%) | 0.364 |
| Hypocalcaemia | 82 (42.5%) | 22 (61.1%) | 104 (45.4%) | 0.039 |
| Elevated ESR | 108 (56%) | 35 (97.2%) | 143 (62.4%) | <0.001 |
| Elevated CRP level | 123 (63.7%) | 34 (94.4%) | 157 (68.6%) | <0.001 |
| Prolonged Prothrombin Time (PT) | 66 (34.2%) | 24 (66.7%) | 90 (39.3%) | <0.001 |
| Prolonged Partial Thromboplastin Time (PTT) | 72 (37.3%) | 25 (69.4%) | 97 (42.4%) | <0.001 |
| Prolonged INR | 66 (34.2%) | 24 (66.7%) | 90 (39.3%) | <0.001 |
| Neutrophilia | 165 (85.5%) | 33 (91.7%) | 198 (86.5%) | 0.320 |
| Lymphopenia | 186 (96.4%) | 34 (94.4%) | 220 (96.1%) | 0.585 |
| High blood urea | 11 (5.7%) | 8 (22.2%) | 19 (8.3%) | <0.001 |
| High serum creatinine | 2 (1%) | 4 (11.1%) | 6 (2.6%) | <0.001 |